As of Nov 5, 2025, the CLB stock has a PE ratio of 22.43. The calculation is based on the latest EPS of $0.7 and the stock price of $15.7 per share. An increase of 6% has been observed in the PE ratio compared to its average of 21.2 of the past four quarters.
The mean historical PE ratio of Core Laboratories N V over the last ten years is 47.25. The current 22.43 price-to-earnings ratio is 53% less than the historical average. Analyzing the last ten years, CLB's PE ratio reached its highest point in the Mar 2022 quarter at 143.77, with a price of $31.63 and an EPS of $0.22. The Dec 2019 quarter saw the lowest point at 16.38, with a price of $37.67 and an EPS of $2.3.
Maximum annual increase: 102.03% in 2016
Maximum annual decrease: -53.69% in 2023
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 25.09 | 12.26% | $17.31 | $0.69 |
| 2023 | 22.35 | -53.69% | $17.66 | $0.79 |
| 2022 | 48.26 | -4.81% | $20.27 | $0.42 |
| 2021 | 50.7 | N/A | $22.31 | $0.44 |
| 2020 | N/A | N/A | $26.51 | -$2.2 |
| 2019 | 16.38 | -50.57% | $37.67 | $2.3 |
| 2018 | 33.14 | -43.13% | $59.66 | $1.8 |
| 2017 | 58.27 | -28.64% | $109.55 | $1.88 |
| 2016 | 81.66 | 102.03% | $120.04 | $1.47 |
| 2015 | 40.42 | 94.8% | $108.74 | $2.69 |
| 2014 | 20.75 | -42.3% | $120.34 | $5.8 |
| 2013 | 35.96 | 50.65% | $190.95 | $5.31 |
| 2012 | 23.87 | -16.42% | $109.31 | $4.58 |
| 2011 | 28.56 | 3.59% | $113.95 | $3.99 |
| 2010 | 27.57 | 15.31% | $89.05 | $3.23 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2025 | 17.66 | -0.34% | $12.36 | $0.7 |
| Jun 2025 | 17.72 | -26.72% | $11.52 | $0.65 |
| Mar 2025 | 24.18 | -3.63% | $14.99 | $0.62 |
| Dec 2024 | 25.09 | -21.47% | $17.31 | $0.69 |
| Sep 2024 | 31.95 | -18.12% | $18.53 | $0.58 |
| Jun 2024 | 39.02 | 85.02% | $20.29 | $0.52 |
| Mar 2024 | 21.09 | -5.64% | $17.08 | $0.81 |
| Dec 2023 | 22.35 | -18.07% | $17.66 | $0.79 |
| Sep 2023 | 27.28 | -0.26% | $24.01 | $0.88 |
| Jun 2023 | 27.35 | -36.75% | $23.25 | $0.85 |
| Mar 2023 | 43.24 | -10.4% | $22.05 | $0.51 |
| Dec 2022 | 48.26 | 25.32% | $20.27 | $0.42 |
| Sep 2022 | 38.51 | -61.12% | $13.48 | $0.35 |
| Jun 2022 | 99.05 | -31.11% | $19.81 | $0.2 |
| Mar 2022 | 143.77 | 183.57% | $31.63 | $0.22 |
The current PE ratio of CLB is under its 3, 5 and 10-year averages.
Core Laboratories N V's price to earnings (P/E) of 22.43 is higher than the Energy sector, the industry and its peers average. Looking at the Energy sector average of 15.84, Core Laboratories N V's price to earnings (P/E) is 42% higher.
When compared to its peer HLX, CLB's PE ratio is lower, but it is higher than SLB's and FI's. Core Laboratories N V's PE ratio is trading above the peer average of 14.92.
| Stock name | PE ratio | Market cap |
|---|---|---|
| FI Fiserv, Inc. | 9.5 | $33.15B |
| OII Oceaneering International Inc | 9.79 | $2.26B |
| SLB Schlumberger Limited | 13.93 | $54.32B |
| HAL Halliburton Co | 17.98 | $23B |
| CLB Core Laboratories N V | 21.84 | $711.95M |
| HLX Helix Energy Solutions Group Inc | 22.76 | $970.73M |
The price to earnings ratio for CLB stock as of Nov 5, 2025, stands at 22.43.
The average PE ratio for CLB stock over the past 3 years is 28.77.
The average PE ratio for CLB stock over the past 5 years is 44.28.
The highest quarterly PE ratio in the last ten years has been 143.77 and it was in the Mar 2022 quarter.
CLB's current price to earnings ratio is 53% below its 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Nov 5, 2025), Core Laboratories N V's share price is $15.7. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2025 is $0.7. Therefore, Core Laboratories N V's price to earnings ratio for today is 22.43. PE RATIO(22.43) = STOCK PRICE($15.7) / TTM EPS($0.7)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.